Recent findings suggest that the pathogenesis of coronary heart disease begins in utero. Babies who are small at birth or in infancy have high rates of coronary heart disease, stroke, hypertension, and diabetes in adult life. [1] [2] [3] This is found in babies who are born small for their gestational age rather than in those born prematurely. 2 The effect is not confined to babies with intrauterine growth retardation' defined by birth weight at the lowest centiles for gestational age, but is seen in babies of average or above average weight. Some of these babies are small in relation to the size of their placentas2; others are thin at birth, or short in relation to the size of their heads4; in others average birth weight is followed by below average infant weight gain.' Programming One interpretation of these findings is that processes associated with low rates of fetal and infant growth programme cardiovascular disease and diabetes. Numerous animal experiments have shown that poor nutrition, and other influences that reduce growth during critical periods of early life, may permanently affect the structure and physiology of a range of organs and tissues." This is known as programming. A simple example in humans is the permanent deformity of the pelvic bones caused by rickets in infancy. The long-term consequences of early growth constraint depend on its timing, because different tissues mature at different stages of fetal life and infancy. Consistent with this, babies with different patterns of reduced fetal growth have different abnormalities as adults.
Geographical studies Surprisingly perhaps it was geographical studies that gave the first clue that coronary heart disease might be a consequence of impaired early development of blood vessels, the liver, endocrine pancreas, and other tissues. An analysis of the large differences in death rates from coronary heart disease between different areas of England and Wales showed that they paralleled similar differences in neonatal mortality in the early years of the century. Studies of individuals Examination of samples of men and women still living in Hertfordshire and Preston has shown that birthweight and infant weight are associated with adult blood pressure; glucose tolerance; plasma concentrations of fibrinogen, factor VII, and apolipoprotein B; and with a tendency to store fat abdominally rather than peripherally.2410 These associations parallel those with death rates from cardiovascular disease in that higher early weight is associated with lower levels of each risk factor. The associations are remarkably strong and graded. For example, the prevalence of impaired glucose tolerance or noninsulin dependent diabetes among men aged 64 years falls progressively from 40% among those with birth weights of 5-5 pounds or less to 14% among those with birth weights of 9 5 pounds or more.' Among men with birth weights of 6-5 pounds the risk of developing syndrome X (hypertension, diabetes and lipid disorders) is ten times greater than among men with birth weights of more than 9 5 pounds."
A striking feature of these findings is that different risk factors are each related to different patterns of early growth. For example, blood pressure is related to birth weight but not independently to weight at one year. 4 This suggests that the critical period when blood pressure is sensitive to programming is during fetal life not infancy. In contrast, plasma total and low density lipoprotein cholesterol concentrations are related to the method and duration of infant feeding. Men who were exclusively bottle fed or breast fed beyond one year have high plasma cholesterol concentrations and high death rates from coronary heart disease.'0 These findings echo experiments on animals showing that lipid metabolism can be programmed by early feeding.7 8 Reduced early growth leads to higher levels of coronary risk factors within each social class. Where a risk factor is influenced by adult lifestyle (for example, plasma fibrinogen by smoking or impaired glucose tolerance by obesity) Editorial the effects of lifestyle add to those of early growth.12 Thus the highest prevalence of impaired glucose tolerance is found in people who had low birth weight but are currently obese.3 Critics of research into programming nevertheless maintain that people who had constrained early growth may continue to be exposed to an adverse environment in childhood and adult life, and it may be this later environment which produces the effects now being attributed to impaired early development.'3 This criticism is unlikely to be correct. The relations with early growth constraint are strong, graded, and specific and are supported by animal research. It is more reasonable to attribute them to programming than to unknown influences in the adult environment defined only in such general terms as "psychosocial stress".
The future The conclusion that coronary heart disease is programmed raises several questions. What influences fetal growth? How does the fetus respond? How are the longterm cardiovascular, metabolic, and endocrine consequences programmed? Answers to these are beginning to emerge.
A set of obstetric records in Sharoe Green Hospital, Preston, provided the opportunity to examine groups of men and women, now aged around 50 years, whose measurements at birth were recorded in detail. In those who had had large placentas in relation to their birth weight systolic pressure was more than 20 mm Hg higher.2 Disproportionately large placental size is a recognised consequence of maternal undernutrition. It occurs in babies whose mothers were anaemic during pregnancy, and can be produced in sheep by depriving the ewe of food in early pregnancy.' 46 Maternal undernutrition is suspected as an important influence which slows fetal growth and programmes coronary heart disease.'2 Recent studies of 4 year old children in Salisbury have shown that those who had large placental weight in relation to birth weight have higher blood pressure, in the same way as in older people.'7 We must therefore conclude that maternal undernutrition still affects fetal growth today, a conclusion that is consistent with the high incidence of pregnancy anaemia. ' '7 Studies of glucose tolerance are giving an insight into the processes whereby impaired early development leads to adult disease. Low weight gain in fetal life and infancy is associated with raised plasma concentrations of 32-33 split proinsulin in adult life, evidence of insulin production by a relatively small complement of pancreatic fi cells.3 The fi cells develop during fetal life and in infancy and impaired development of the endocrine pancreas is a feature of intrauterine growth retardation. It is proposed that nutritional and other influences which impair early growth reduce the # cell mass. If this is followed by attrition of fi cells with aging or by insulin resistance, usually in association with obesity, non-insulin dependent diabetes will develop.
Research into the fetal origins of coronary heart disease is now being carried out in several centres. We can expect to know considerably more about it in the near future.
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